COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,844 Articles (22,553 medRxiv, 8,291 bioRxiv)

Most recent first Previous |  Page 2249: Articles 22481-22490  | Next

App-based symptom tracking to optimize SARS-CoV-2 testing strategy using machine learning
DANTAS, L. F., PERES, I. T., BASTOS, L. S. L., MARCHESI, J. F., DE SOUZA, G. F. G., GELLI, J. G. M., BAIAO, F. A., MACAIRA, P., HAMACHER, S., BOZZA, F. A.
10.1101/2020.09.01.20186049 — Posted: 2020-09-03
SARS-CoV-2 Protein in Wastewater Mirrors COVID-19 Prevalence.
Neault, N., Baig, A. T., Graber, T. E., D'Aoust, P. M., Mercier, E., Alexandrov, I., Crosby, D., Mayne, J., Pounds, T., MacKenzie, M., Figeys, D., MacKenzie, A. E., Delatolla, R.
10.1101/2020.09.01.20185280 — Posted: 2020-09-03
Age-dependence of healthcare interventions for SARS-CoV-2 infection in Ontario, Canada
Papst, I., Li, M., Champredon, D., Bolker, B. M., Dushoff, J., Earn, D. J. D.
10.1101/2020.09.01.20186395 — Posted: 2020-09-03
Systematic evaluation of SARS-CoV-2 spike protein derived peptides for diagnosis of COVID-19 patients
Li, Y., Lai, D., Lei, Q., Xu, Z., Hou, H., Shan, H., Wang, F., Fan, X., Tao, S.-c.
10.1101/2020.09.01.20186387 — Posted: 2020-09-03
The Impact of Psychology Interventions on Changing Mental Health Status and Sleep Quality in University Students during the COVID-19 Pandemic
Xiao, J., Jiang, Y., Zhang, Y., Gu, X., Ma, W., Zhuang, B., Zhou, Z., Sang, L., Luo, Y., Lian, Y.
10.1101/2020.09.01.20186411 — Posted: 2020-09-03 Discussion: Offsite
Healthcare Worker Attendance During the Early Stages of the COVID-19 Pandemic: A Longitudinal Analysis of Daily Fingerprint-Verified Data from All Public-Sector Secondary and Tertiary Care Facilities in Bangladesh
Do, D., Sarker, M., Chen, S., Lenjani, A., Tikka, P., Barnighausen, T., Geldsetzer, P.
10.1101/2020.09.01.20186445 — Posted: 2020-09-03
Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex
Bartolome, A., Liang, J., Wang, P., Ho, D. D., Pajvani, U. B.
10.1101/2020.09.01.277954 — Posted: 2020-09-03
Cross-reactive antibody responses against SARS-CoV-2 and seasonal common cold coronaviruses
Vogl, T., Klompus, S., Leviathan, S., Kalka, I., Godneva, A., Shinar, E., Weinberger, A., Segal, E.
10.1101/2020.09.01.20182220 — Posted: 2020-09-03 Discussion: Offsite
Dark matter, second waves and epidemiological modelling
Friston, K., Costello, A., Pillay, D.
10.1101/2020.09.01.20185876 — Posted: 2020-09-03 Discussion: Onsite
Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?
Sieiro Santos, C., Casas Fernandez, X., Moriano Morales, C., Alvarez Diez, E., Alvarez Castro, C., Lopez Robles, A., Perez Sandoval, T.
10.1101/2020.09.01.20184333 — Posted: 2020-09-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).